FA
ABBV icon

Fiduciary Alliance’s AbbVie ABBV Stock Holding History

Fiduciary Alliance’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.53M Buy
21,965
+243
+1% +$52.3K 0.37% 73
2026
Q1 		$4.53M Buy
21,722
+371
+2% +$82.3K 0.27% 91
2025
Q4 		$4.88M Buy
21,351
+375
+2% +$85.4K 0.32% 76
2025
Q3 		$4.86M Sell
20,976
-67
-0.3% -$13.6K 0.33% 77
2025
Q2 		$3.91M Buy
21,043
+4,117
+24% +$765K 0.29% 83
2025
Q1 		$3.55M Buy
16,926
+1,079
+7% +$210K 0.35% 71
2024
Q4 		$2.82M Buy
15,847
+10,947
+223% +$2.01M 0.28% 85
2024
Q3 		$968K Buy
4,900
+979
+25% +$183K 0.13% 112
2024
Q2 		$651K Buy
3,921
+1,481
+61% +$245K 0.11% 109
2024
Q1 		$441K Sell
2,440
-164
-6% -$28.3K 0.08% 132
2023
Q4 		$404K Sell
2,604
-38
-1% -$5.54K 0.08% 126
2023
Q3 		$394K Buy
2,642
+407
+18% +$59.7K 0.09% 119
2023
Q2 		$301K Buy
2,235
+904
+68% +$133K 0.06% 127
2023
Q1 		$212K Sell
1,331
-11
-0.8% -$1.68K 0.05% 127
2022
Q4 		$217K Buy
+1,342
New +$206K 0.06% 125

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Fiduciary Alliance's ABBV Position: Q2 2026 in Review

Fiduciary Alliance increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $52.3K and bringing the position to 21,965 shares worth $5.53M. The position accounts for 0.37% of the portfolio, ranked #73.

Fiduciary Alliance first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 1,042 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fiduciary Alliance held 21,965 shares of AbbVie worth $5.53M as of Q2 2026.
  • Fiduciary Alliance bought 243 AbbVie shares in Q2 2026, an estimated $52.3K.
  • AbbVie made up 0.37% of Fiduciary Alliance's portfolio in Q2 2026, its #73 holding.
  • Fiduciary Alliance first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 1,042 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.